EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Apolipoprotein-L1 (APOL1): From Sleeping Sickness to Kidney Disease

Etienne Pays iD

Cells · 2024

DOI: 10.3390/cells13201738 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Etienne Pays. Beteiligte Einrichtung: Laboratory of Molecular Parasitology, Institut de Biologie et de Médecine Moléculaires (IBMM), Université Libre de Bruxelles, 6041 Gosselies, Belgium. Hauptthemen laut MEDLINE: Trypanosomiasis, African, Apolipoprotein L1, Kidney Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apolipoprotein-L1 (APOL1) is a membrane-interacting protein induced by inflammation, which confers human resistance to infection by African trypanosomes. APOL1 kills Trypanosoma brucei through induction of apoptotic-like parasite death, but two T. brucei clones acquired resistance to APOL1, allowing them to cause sleeping sickness. An APOL1 C-terminal sequence alteration, such as occurs in natural West African variants G1 and G2, restored human resistance to these clones. However, APOL1 unfolding induced by G1 or G2 mutations enhances protein hydrophobicity, resulting in kidney podocyte dysfunctions affecting renal filtration. The mechanism involved in these dysfunctions is debated. The ability of APOL1 to generate ion pores in trypanosome intracellular membranes or in synthetic membranes was provided as an explanation. However, transmembrane insertion of APOL1 strictly depends on acidic conditions, and podocyte cytopathology mainly results from secreted APOL1 activity on the plasma membrane, which occurs under non-acidic conditions. In this review, I argue that besides inactivation of APOL3 functions in membrane dynamics (fission and fusion), APOL1 variants induce inflammation-linked podocyte toxicity not through pore formation, but through plasma membrane disturbance resulting from increased interaction with cholesterol, which enhances cation channels activity. A natural mutation in the membrane-interacting domain (N264K) abrogates variant APOL1 toxicity at the expense of slightly increased sensitivity to trypanosomes, further illustrating the continuous mutual adaptation between host and parasite.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypanosomiasis, AfricanApolipoprotein L1Kidney DiseasesHumansAnimalsTrypanosoma brucei bruceiPodocytes

Stichwörter der Autor:innen

APOL1 risk variantsARF1INF-I inflammationN264K variantNCS1PI4KBapoptosiscation channelscholesterol microdomainschronic kidney diseasemembrane dynamicsmitochondrion fissionmitophagysleeping sickness

Substanzen

Apolipoprotein L1APOL1 protein, human

Autor:innen und Institutionen

  • Laboratory of Molecular Parasitology, Institut de Biologie et de Médecine Moléculaires (IBMM), Université Libre de Bruxelles, 6041 Gosselies, Belgium.

ORCID-Profile: Etienne Pays

Förderung

  • European Research Council

Zitieren

APA

Pays, E. (2024). Apolipoprotein-L1 (APOL1): From Sleeping Sickness to Kidney Disease. Cells. https://doi.org/10.3390/cells13201738

Vancouver

Pays E. Apolipoprotein-L1 (APOL1): From Sleeping Sickness to Kidney Disease. Cells. 2024. doi:10.3390/cells13201738

BibTeX
@article{Pays2024,
  author = {Pays, Etienne},
  title = {Apolipoprotein-L1 (APOL1): From Sleeping Sickness to Kidney Disease},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13201738}
}
Kostenlos starten →